GEN-MKT-18-7897-A
Feb 17, 2016 | Blogs, Environmental / Industrial, Food / Beverage | 0 comments
Between 3-6 November 2015, the Recent Advances in Food Analysis (RAFA) 2015 Symposium took place in Prague, Czech Republic.
With over 800 scientists in attendance, visitors were treated to 132 lectures, 15 seminars, 6 workshops and over 500 posters presenting the latest in food testing methodology. Amongst the hive of activity was our very own Andre Schreiber, presenting on ways to ignite your routine testing methods with new and existing technology.
If you were unable to attend RAFA 2015 or would like to see Andre’s talk again you can watch the full 45-minute seminar below.
Be sure to leave a comment below as Andre will be able to respond to any questions or feedback, and if you’d like to read more about the talk you can download the full Igniting Your Routine Testing Methods Presentation.Download the Full Presentation >
Produced by certain moulds, thriving in crops such as grain, nuts and coffee, mycotoxins have contaminated agriculture and food production industries for a long time. To intensify the challenge, mycotoxins are resilient, not easily broken down and ensuring the safety of food supply chains requires comprehensive solutions and we are here to share those solutions with you.
Electron-Activated Dissociation (EAD) is transforming the fields of metabolomics and lipidomics by providing enhanced fragmentation techniques that offer deeper insights into molecular structures. In September, Technology Networks hosted a webinar, “Enhancing Mass-Based Omics Analysis in Model Organisms,” featuring Dr. Valentina Calabrese from the Institute of Analytical Sciences at the University of Lyon. Valentina shared her insights on improving omics-based mass spectrometry analysis for toxicology studies using model organisms, particularly in metabolomics and lipidomics. This blog explores the additional functionalities EAD offers, its benefits in untargeted workflows, its incorporation into GNPS and molecular networking, and the future role it could play in these scientific domains.
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has gained significant attention in the clinical laboratory due to its ability to provide best-in-class sensitivity and specificity for the detection of clinically relevant analytes across a wide range of assays. For clinical laboratories new to LC-MS/MS, integrating this technology into their daily routine operations may seem like a daunting task. Developing a clear outline and defining the requirements needed to implement LC-MS/MS into your daily operations is critical to maximize the productivity and success of your clinical laboratory.
Posted by
You must be logged in to post a comment.
Share this post with your network